Geneos Wealth Management Inc. Biocryst Pharmaceuticals Inc Transaction History
Geneos Wealth Management Inc.
- $3.92 Billion
- Q2 2025
A detailed history of Geneos Wealth Management Inc. transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Geneos Wealth Management Inc. holds 1,365 shares of BCRX stock, worth $8,763. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,365
Previous 1,277
6.89%
Holding current value
$8,763
Previous $9,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding BCRX
# of Institutions
315Shares Held
201MCall Options Held
930KPut Options Held
553K-
Vanguard Group Inc Valley Forge, PA20.5MShares$132 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$128 Million0.0% of portfolio
-
State Street Corp Boston, MA8.51MShares$54.6 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.46MShares$54.3 Million9.06% of portfolio
-
Alkeon Capital Management LLC New York, NY5.71MShares$36.7 Million0.09% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.19B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...